SK
Subramanian Kavitha
About Subramanian Kavitha
Subramanian Kavitha has 21 years in corporate governance. Holds Director role. Currently with 2 companies, including Vals Lifescience Private Limited and Prim Drugs & Pharmaceuticals (India) Private Limited. Formerly with 2 companies, such as Seegee Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Vals Lifescience Private Limited
U86904TN2024PTC169721
|
Director | 25 Apr 2024 | 2024 | Active |
Prim Drugs & Pharmaceuticals (India) Private Limited
U51909TN2009PTC073934
|
Director | 15 Dec 2009 | 2009 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Seegee Pharmaceutical Private Limited
U24231PY2004PTC001813
|
Director | 01 Apr 2005 | 2004 | Strike Off |
Prim Research Laboratories (India) Private Limited
U73100TN2003PTC050243
|
Director | 25 Jul 2008 | 2003 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subramanian Kavitha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subramanian Kavitha
Subramanian Kavitha has 21 years in corporate governance. Holds Director role. Currently with 2 companies, including Vals Lifescience Private Limited and Prim Drugs & Pharmaceuticals (India) Private Limited. Formerly with 2 companies, such as Seegee Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.
Subramanian Kavitha is associated with 2 companies as Director.
Subramanian Kavitha has expertise in General Business.
Subramanian Kavitha has 21 years in corporate governance.